Utilisateur
• FSH, follicle-stimulating hormone.
• GnRH gonadotrophin-releasing hormone.
• ICSH, interstitial cell-stimulating hormone.
GnRH
FSH
LH
5α-dihydrotestosterone which is metabolite from testosterone and responsible of androgenic action
because it is the natural androgen in humans
Synthesised in:
• Leydig cells of the testes in males.
• Ovaries in females (small amount)
• Adrenal gland (both sexual)
Hypogonadism. There is no maturation of the male genetic organs so it may be a problem in the hypothalamus, so the testosterone is not produced.
it may be primary hypogonadism due to testicular dysfunction.
or secondary hypogonadism due to dailure of the hypotalamus or pituitary.
false
albumin and androgen binding pretein in sertoli cells
liver
used in the treatment of patients producing excessive amounts of testosterone
Cyproterone: It is a partial agonist at androgen receptors, competing with dihydrotestosterone for receptors in androgen-sensitive target tissues
– Used as part of treatment of prostatic cancer
Finasteride:inhibits the enzyme (5α-reductase) enzyme that converts testosterone to dihydrotestosterone
– Used in benign prostatic hypertrophy (enlarged prostate)
Flutamide:acts as competitive inhibitor of androgens at
target cells.
– Used as part of treatment of prostatic cancer.
Ketoconazole: used primarily in the treatment of fungal disease, is an inhibitor of adrenal and gonadal steroid synthesis.
sulfasalazine, an anti-inflammatory drug for rheumatoid arthritis